Researcher Profile
Kim, Bo Kyung(김보경)
93
Personalized Genomic Medicine Research Center (유전체맞춤의료전문연구단)
- Technology
- Research Keywords
- Cancer ; Gene regulation ; Target discovery and verification
- 암 ; 유전자 발현 조절 ; 타겟 발굴/검증
Keywords Cloud
KRIBB Co-Working
Results 1-20 of 93 (Search time: 0.006 seconds).
| No. | Year | Title | Type |
|---|---|---|---|
| 93 | 2023 | 2023Article TNF-α secreted from macrophages increases the expression of prometastatic integrin αV in gastric cancerInternational Journal of Molecular Sciences, vol. 24, no. 1, pp. 376-376Mi Aie Hwang; Misun Won; Joo-Young Im; Mi-Jung Kang; D H Kweon; Bo Kyung Kim |
Article |
| 92 | 2023 | 2023Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
| 91 | 2022 | 2022Patent SYT11 억제제를 유효성분으로 포함하는 위암 치료용 조성물KR10-2019-0129281 (2019.10.17) / 10-2377702-0000 (2022.03.18)염영일; 원미선; 반현승; 김보경; 박경찬 |
Patent |
| 90 | 2022 | 2022Article Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesisJournal of Experimental & Clinical Cancer Research, vol. 41, pp. 212-212Bo Kyung Kim; Da Mi Kim; Hyunkyung Park; Seon-Kyu Kim; Mi Aie Hwang; Jungwoon Lee; Mi-Jung Kang; Jae Eun Byun; Joo-Young Im; Minho Kang, et al. |
Article |
| 89 | 2022 | 2022Article DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapyExperimental and Molecular Medicine, vol. 54, no. 8, pp. 1236-1249Haejeong Heo; Jong-Hwan Kim; Hyun Jung Lim; Jeong Hwan Kim; M Kim; J Koh; Joo-Young Im; Bo Kyung Kim; Mi Sun Won; Ji Hwan Park, et al. |
Article |
| 88 | 2022 | 2022Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2022.01.01 ~ 2022.12.31 |
Research Project |
| 87 | 2022 | 2022Research Project 암대사를 조절하는 MDH1/2 이중 저해 항암물질 개발 = Development of anti-cancer drug MDH1/2 dual inhibitor controling cancer metabolism연구책임자 : 원미선 / 사업기간 : 2022.01.01 ~ 2023.06.30 |
Research Project |
| 86 | 2021 | Patent | |
| 85 | 2021 | 2021Patent cyb5R3 유전자 또는 단백질을 유효성분으로 포함하는 암 예방 및 치료용 약학적 조성물CN201480064255.2 (2016.05.25) / ZL201480064255.2 (2021.02.26)김동욱; 원미선; 이영주; 반현승; 김보경 |
Patent |
| 84 | 2021 | 2021Article VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-β/ERK/RSK2 signalingBiochimica et Biophysica Acta-Molecular Cell Research, vol. 1868, pp. 118892-118892Joo-Young Im; Da Mi Kim; Hyunkyung Park; Mi-Jung Kang; Da Yoon Kijm; K Y Chang; Bo Kyung Kim; Mi Sun Won |
Article |
| 83 | 2021 | 2021Article DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathwayExperimental and Molecular Medicine, vol. 53, no. 4, pp. 643-653Joo-Young Im; Bo Kyung Kim; S H Yoon; B C Cho; Y M Baek; Mi-Jung Kang; N Kim; Y D Gong; Mi Sun Won |
Article |
| 82 | 2021 | 2021Article Targeting HSF1 as a therapeutic strategy for multiple mechanisms of EGFR inhibitor resistance in EGFR mutant non-small-cell lung cancer = 활성 EGFR 발현 비소세포 폐암의 EGFR 표적항암제에 대한 다중 내성 치료표적으로의 HSF1Cancers, vol. 13, no. 12, pp. 2987-2987Sangah Lee; JiYae Jung; Yu-Jin Lee; Seon-Kyu Kim; Jung Ae Kim; Bo Kyung Kim; Kyung Chan Park; Byoung-Mog Kwon; Dong Cho Han |
Article |
| 81 | 2021 | 2021Research Project 바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2021.01.01 ~ 2021.12.31 |
Research Project |
| 80 | 2021 | 2021Research Project 암대사를 조절하는 MDH1/2 이중 저해 항암물질 개발 = Development of anti-cancer drug MDH1/2 dual inhibitor controling cancer metabolism연구책임자 : 원미선 / 사업기간 : 2021.01.01 ~ 2021.12.31 |
Research Project |
| 79 | 2021 | 2021Research Project 종양미세환경 조절을 통한 위암세포 증식 및 전이 조절 기전 연구연구책임자 : 김보경 / 사업기간 : 2021.03.01 ~ 2022.02.28 |
Research Project |
| 78 | 2020 | 2020Patent 장형 위암의 예후 진단 마커KR10-2018-0125768 (2018.10.22) / 10-2136747-0000 (2020.07.16)원미선; 김보경; 김선규; 박경찬 |
Patent |
| 77 | 2020 | 2020Patent 말릭산 탈수소효소 저해 활성을 갖는 신규 화합물 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물KR10-2018-0027397 (2018.03.08) / 10-2082504 (2020.02.21)원미선; 반현승; 김보경 |
Patent |
| 76 | 2020 | 2020Article DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cellsOncogenesis, vol. 9, pp. 1-1Joo-Young Im; Bo Kyung Kim; K W Lee; So-Young Chun; Mi-Jung Kang; Mi Sun Won |
Article |
| 75 | 2020 | 2020Article The disubstituted adamantyl derivative LW1564 inhibits the growth of cancer cells by targeting mitochondrial respiration and reducing hypoxia-inducible factor (HIF)-1α accumulationExperimental and Molecular Medicine, vol. 52, no. 11, pp. 1845-1856Inhyub Kim; M Kim; Min Kyung Park; R Naik; J H Park; Bo Kyung Kim; Y Choi; K Y Chang; Mi Sun Won; Hyun Seung Ban, et al. |
Article |
| 74 | 2020 | 2020Article Miconazole inhibits signal transducer and activator of transcription 3 signaling by preventing its interaction with DNA damage-induced apoptosis suppressorCancer Science, vol. 111, no. 7, pp. 2499-2507Sung Hoon Yoon; Bo Kyung Kim; Mi-Jung Kang; Joo-Young Im; Mi Sun Won |
Article |